Variable | Response categories | Level of Asthma control | COR (95% CI) | AOR (95% CI) | p-value | |
---|---|---|---|---|---|---|
Controlled | Uncontrolled | |||||
Presence comorbidities | No comorbidity | 46 (75%) | 15 (25%) | 1.000 | 1.000 | Â |
Allergic Rhinitis | 9 (90%) | 1 (10%) | 0.34 (0.04–3) | 0.494 (0.042–5.9) | 0.578 | |
Atopic dermatitis | 10 (59%) | 7 (41%) | 2.1 (0.69–6.6) | 2.597 (0.576–11.7) | 0.214 | |
Both | 7 (41%) | 10 (59%) | 4.4 (1.4–13.5) | 4.56 (1.1–18.7) | 0.035 | |
Controller adherence | Yes | 54 (79.4%) | 14 (20.6%) | 1.000 | 1.000 | Â |
No | 18 (48.6%) | 19 (51.4%) | 0.25 (0.1–0.59) | 3.23 (1.2–10.2) | 0.045 | |
Appropriate Inhaler technique | Yes | 35 (95%) | 2 (5%) | 1.000 | 1.000 | Â |
No | 21 (47%) | 24 (53%) | 5.2 (2.13–12.80) | 3.48 (1.18–10.3) | 0.024 | |
Place of care | SPHMMC | 33 (79%) | 9 (21%) | 1.000 | 1.000 | Â |
TASH | 28 (78%) | 11 (28%) | 1.4 (0.5–3.9) | 1.37 (0.37–5.0) | 0.636 | |
Yekatit 12 | 11 (46%) | 13 (54%) | 4.3 (1.5–12.9) | 4.72 (1.13–19.8) | 0.034 |